trending Market Intelligence /marketintelligence/en/news-insights/trending/bghirsocwfkv0zfh9g_ntw2 content esgSubNav
In This List

Tonix Pharmaceuticals director steps down; replacement named

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Tonix Pharmaceuticals director steps down; replacement named

Tonix Pharmaceuticals Holding Corp. said Stuart Davidson stepped down from the company's board.

The company has added David Grange to replace Davidson, who had been a board member since 2011.

Grange is currently with Pharm-Olam International Ltd. as CEO.